Rank | Gene Set | Z-score |
---|---|---|
1 | alanine transport (GO:0032328) | 6.36818716 |
2 | L-serine transport (GO:0015825) | 5.41250424 |
3 | hemidesmosome assembly (GO:0031581) | 5.30823071 |
4 | negative regulation of astrocyte differentiation (GO:0048712) | 5.07917881 |
5 | positive regulation of cellular amide metabolic process (GO:0034250) | 4.97448861 |
6 | sodium ion export (GO:0071436) | 4.87499369 |
7 | cellular potassium ion homeostasis (GO:0030007) | 4.84983695 |
8 | C4-dicarboxylate transport (GO:0015740) | 4.77215066 |
9 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 4.72861433 |
10 | amino acid import (GO:0043090) | 4.69615252 |
11 | endodermal cell differentiation (GO:0035987) | 4.67970586 |
12 | serine transport (GO:0032329) | 4.63808458 |
13 | cell communication by electrical coupling (GO:0010644) | 4.59853875 |
14 | L-amino acid import (GO:0043092) | 4.51836953 |
15 | cellular response to cholesterol (GO:0071397) | 4.45953684 |
16 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 4.30670448 |
17 | glial cell proliferation (GO:0014009) | 4.21987064 |
18 | protein heterotrimerization (GO:0070208) | 4.13756665 |
19 | low-density lipoprotein particle remodeling (GO:0034374) | 4.13522784 |
20 | dermatan sulfate biosynthetic process (GO:0030208) | 4.13258140 |
21 | collagen fibril organization (GO:0030199) | 4.09032983 |
22 | chondroitin sulfate catabolic process (GO:0030207) | 4.04908399 |
23 | dermatan sulfate metabolic process (GO:0030205) | 4.04656587 |
24 | blood vessel maturation (GO:0001955) | 3.98828548 |
25 | regulation of beta-amyloid formation (GO:1902003) | 3.94624519 |
26 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 3.90882472 |
27 | cellular response to sterol (GO:0036315) | 3.87874045 |
28 | extracellular matrix assembly (GO:0085029) | 3.87196978 |
29 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.77917626 |
30 | adhesion of symbiont to host cell (GO:0044650) | 3.74776372 |
31 | virion attachment to host cell (GO:0019062) | 3.74776372 |
32 | regulation of phospholipid biosynthetic process (GO:0071071) | 3.73380783 |
33 | ovulation cycle (GO:0042698) | 3.73261853 |
34 | cellular sodium ion homeostasis (GO:0006883) | 3.72072792 |
35 | chondrocyte proliferation (GO:0035988) | 3.71834040 |
36 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.61899381 |
37 | potassium ion import (GO:0010107) | 3.55904679 |
38 | extracellular fibril organization (GO:0043206) | 3.53191081 |
39 | adhesion of symbiont to host (GO:0044406) | 3.51556454 |
40 | negative regulation of response to reactive oxygen species (GO:1901032) | 3.50400329 |
41 | cell migration involved in heart development (GO:0060973) | 3.49485219 |
42 | cell adhesion mediated by integrin (GO:0033627) | 3.47797248 |
43 | regulation of hydrogen peroxide-induced cell death (GO:1903205) | 3.45583225 |
44 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 3.43175674 |
45 | collagen metabolic process (GO:0032963) | 3.42829388 |
46 | skin morphogenesis (GO:0043589) | 3.41233944 |
47 | collagen catabolic process (GO:0030574) | 3.37346979 |
48 | proline transport (GO:0015824) | 3.37316556 |
49 | cell-substrate junction assembly (GO:0007044) | 3.36241581 |
50 | regulation of astrocyte differentiation (GO:0048710) | 3.34159548 |
51 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 3.33787977 |
52 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.30094876 |
53 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 3.28814120 |
54 | locomotory exploration behavior (GO:0035641) | 3.28227861 |
55 | keratan sulfate catabolic process (GO:0042340) | 3.26809010 |
56 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.26737339 |
57 | barbed-end actin filament capping (GO:0051016) | 3.26390163 |
58 | extracellular matrix disassembly (GO:0022617) | 3.21114492 |
59 | multicellular organismal macromolecule metabolic process (GO:0044259) | 3.19706258 |
60 | cGMP-mediated signaling (GO:0019934) | 3.16611666 |
61 | vascular endothelial growth factor signaling pathway (GO:0038084) | 3.16250357 |
62 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.14907245 |
63 | gamma-aminobutyric acid transport (GO:0015812) | 3.13392382 |
64 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.11073643 |
65 | sequestering of extracellular ligand from receptor (GO:0035581) | 3.09310121 |
66 | fibril organization (GO:0097435) | 3.08709878 |
67 | negative regulation of sodium ion transport (GO:0010766) | 3.08369642 |
68 | negative regulation of smoothened signaling pathway (GO:0045879) | 3.07024368 |
69 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 3.06498972 |
70 | multicellular organismal catabolic process (GO:0044243) | 3.06011735 |
71 | response to auditory stimulus (GO:0010996) | 3.05571732 |
72 | peripheral nervous system axon ensheathment (GO:0032292) | 3.03432625 |
73 | myelination in peripheral nervous system (GO:0022011) | 3.03432625 |
74 | apoptotic cell clearance (GO:0043277) | 3.02254641 |
75 | multicellular organismal metabolic process (GO:0044236) | 3.02232721 |
76 | potassium ion homeostasis (GO:0055075) | 3.01801554 |
77 | adenine nucleotide transport (GO:0051503) | 3.00095219 |
78 | positive regulation of osteoblast proliferation (GO:0033690) | 2.97710800 |
79 | basement membrane organization (GO:0071711) | 2.95856409 |
80 | lens fiber cell development (GO:0070307) | 2.92377280 |
81 | protein localization to endosome (GO:0036010) | 2.90519603 |
82 | regulation of extracellular matrix disassembly (GO:0010715) | 2.89967308 |
83 | atrial cardiac muscle cell action potential (GO:0086014) | 2.89368196 |
84 | extracellular matrix organization (GO:0030198) | 2.86351347 |
85 | extracellular structure organization (GO:0043062) | 2.85177825 |
86 | type B pancreatic cell proliferation (GO:0044342) | 2.85107495 |
87 | response to histamine (GO:0034776) | 2.84084658 |
88 | negative regulation of stress fiber assembly (GO:0051497) | 2.84083294 |
89 | regulation of glomerular filtration (GO:0003093) | 2.83415650 |
90 | regulation of membrane repolarization (GO:0060306) | 2.80561677 |
91 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.80164948 |
92 | negative regulation of glial cell differentiation (GO:0045686) | 2.80103021 |
93 | stress fiber assembly (GO:0043149) | 2.79589851 |
94 | positive regulation of alcohol biosynthetic process (GO:1902932) | 2.76992510 |
95 | acidic amino acid transport (GO:0015800) | 2.76782812 |
96 | central nervous system myelination (GO:0022010) | 2.75607311 |
97 | axon ensheathment in central nervous system (GO:0032291) | 2.75607311 |
98 | substrate-dependent cell migration (GO:0006929) | 2.75575373 |
99 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.74582547 |
100 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.74350317 |
101 | kidney mesenchyme development (GO:0072074) | 2.72164686 |
102 | glomerular basement membrane development (GO:0032836) | 2.71989435 |
103 | regulation of inositol phosphate biosynthetic process (GO:0010919) | 2.71084040 |
104 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.70506214 |
105 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.69541141 |
106 | neurotransmitter uptake (GO:0001504) | 2.69033286 |
107 | regulation of cellular amide metabolic process (GO:0034248) | 2.68338345 |
108 | response to gravity (GO:0009629) | 2.68131397 |
109 | bone trabecula formation (GO:0060346) | 2.67411270 |
110 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.67086821 |
111 | metanephric mesenchyme development (GO:0072075) | 2.67071384 |
112 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.66867940 |
113 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.65954857 |
114 | venous blood vessel morphogenesis (GO:0048845) | 2.65818304 |
115 | cellular response to vitamin (GO:0071295) | 2.65484962 |
116 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.64896443 |
117 | response to cholesterol (GO:0070723) | 2.64262710 |
118 | negative regulation of chondrocyte differentiation (GO:0032331) | 2.63592816 |
119 | auditory behavior (GO:0031223) | 2.61110214 |
120 | glial cell migration (GO:0008347) | 2.60847611 |
121 | axon extension involved in axon guidance (GO:0048846) | 2.60395280 |
122 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.60395280 |
123 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.60171752 |
124 | protein retention in ER lumen (GO:0006621) | 2.60066057 |
125 | peptidyl-proline hydroxylation (GO:0019511) | 2.59106807 |
126 | regulation of tight junction assembly (GO:2000810) | 2.57110387 |
127 | negative regulation of smooth muscle cell migration (GO:0014912) | 2.56386319 |
128 | regulation of triglyceride biosynthetic process (GO:0010866) | 2.54867542 |
129 | cellular modified amino acid catabolic process (GO:0042219) | 2.54516813 |
130 | chondrocyte development (GO:0002063) | 2.53548474 |
131 | positive regulation of axon extension (GO:0045773) | 2.52730295 |
132 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.52216769 |
133 | layer formation in cerebral cortex (GO:0021819) | 2.50965026 |
134 | response to dietary excess (GO:0002021) | 2.50329721 |
135 | neuroblast proliferation (GO:0007405) | 2.49811802 |
136 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.49768458 |
137 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.48360267 |
138 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.48181991 |
139 | response to sterol (GO:0036314) | 2.47558306 |
140 | regulation of early endosome to late endosome transport (GO:2000641) | 2.47547749 |
141 | regulation of gonadotropin secretion (GO:0032276) | 2.47265781 |
142 | reverse cholesterol transport (GO:0043691) | 2.46670295 |
143 | purine nucleotide transport (GO:0015865) | 2.45511621 |
144 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 2.45415336 |
145 | mesenchymal-epithelial cell signaling (GO:0060638) | 2.45225863 |
146 | heart trabecula morphogenesis (GO:0061384) | 2.45170092 |
147 | cell communication involved in cardiac conduction (GO:0086065) | 2.44679238 |
148 | chondroitin sulfate metabolic process (GO:0030204) | 2.42376211 |
149 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.42364201 |
150 | renal filtration (GO:0097205) | 2.42362404 |
151 | anatomical structure maturation (GO:0071695) | 2.42280501 |
152 | daunorubicin metabolic process (GO:0044597) | 2.41995504 |
153 | polyketide metabolic process (GO:0030638) | 2.41995504 |
154 | doxorubicin metabolic process (GO:0044598) | 2.41995504 |
155 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G- | 2.41882575 |
156 | endothelial cell chemotaxis (GO:0035767) | 2.41711173 |
157 | positive regulation of extracellular matrix organization (GO:1903055) | 2.40949319 |
158 | purine ribonucleotide transport (GO:0015868) | 2.40816632 |
159 | positive regulation of astrocyte differentiation (GO:0048711) | 2.40541014 |
160 | cholesterol catabolic process (GO:0006707) | 2.40214211 |
161 | sterol catabolic process (GO:0016127) | 2.40214211 |
162 | positive regulation of sodium ion transmembrane transport (GO:1902307) | 2.37718520 |
163 | chondroitin sulfate biosynthetic process (GO:0030206) | 2.37038015 |
164 | glycogen catabolic process (GO:0005980) | 2.37013522 |
165 | negative regulation of actin filament bundle assembly (GO:0032232) | 2.36945817 |
166 | smooth muscle tissue development (GO:0048745) | 2.36505701 |
167 | renal system process involved in regulation of blood volume (GO:0001977) | 2.34705381 |
168 | substrate adhesion-dependent cell spreading (GO:0034446) | 2.34029725 |
169 | membrane repolarization (GO:0086009) | 2.33589993 |
170 | phagocytosis, recognition (GO:0006910) | 2.33434246 |
171 | fatty acid homeostasis (GO:0055089) | 2.32371129 |
172 | cortical actin cytoskeleton organization (GO:0030866) | 2.32129776 |
173 | endothelial cell morphogenesis (GO:0001886) | 2.31590435 |
174 | positive regulation of receptor recycling (GO:0001921) | 2.31544707 |
175 | glycosaminoglycan catabolic process (GO:0006027) | 2.31418203 |
176 | semaphorin-plexin signaling pathway (GO:0071526) | 2.31035436 |
177 | negative regulation of catenin import into nucleus (GO:0035414) | 2.30784737 |
178 | regulation of plasminogen activation (GO:0010755) | 2.28156350 |
179 | import into cell (GO:0098657) | 2.27124899 |
180 | astrocyte development (GO:0014002) | 2.26924637 |
181 | cell-matrix adhesion (GO:0007160) | 2.26749843 |
182 | cartilage development involved in endochondral bone morphogenesis (GO:0060351) | 2.26136174 |
183 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.25567883 |
184 | epithelial cell-cell adhesion (GO:0090136) | 2.25525978 |
185 | heparan sulfate proteoglycan biosynthetic process (GO:0015012) | 2.23630121 |
186 | axon extension (GO:0048675) | 2.23448020 |
187 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.23309353 |
188 | wound healing, spreading of epidermal cells (GO:0035313) | 2.23138918 |
189 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.22653561 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.86406204 |
2 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.81842268 |
3 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.63776006 |
4 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.58851198 |
5 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.45796986 |
6 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.41253078 |
7 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.41253078 |
8 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.37861673 |
9 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.36565632 |
10 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.30036472 |
11 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.24804876 |
12 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.23852217 |
13 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.16504843 |
14 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.11509596 |
15 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.08390136 |
16 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.06904892 |
17 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.06564002 |
18 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 2.00654107 |
19 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.91351243 |
20 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.88379083 |
21 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.83565933 |
22 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.81171424 |
23 | * TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.80687785 |
24 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.80144857 |
25 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.74526511 |
26 | * EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.70900045 |
27 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.70032535 |
28 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.69956741 |
29 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.66506361 |
30 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.64993738 |
31 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.63730878 |
32 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.60779501 |
33 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.59018698 |
34 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.53063745 |
35 | RXR_22108803_ChIP-Seq_LS180_Human | 1.52781658 |
36 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.50872137 |
37 | * THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.50491638 |
38 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.47162533 |
39 | TP53_16413492_ChIP-PET_HCT116_Human | 1.46601956 |
40 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.46260410 |
41 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.46163200 |
42 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.45820557 |
43 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.44932361 |
44 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.44368713 |
45 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.39918565 |
46 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.38341270 |
47 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.38192295 |
48 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.37058540 |
49 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.36510385 |
50 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.35585930 |
51 | * TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.33836100 |
52 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.30258771 |
53 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.29371918 |
54 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.29353027 |
55 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.28459711 |
56 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.27362650 |
57 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.26719728 |
58 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.26242322 |
59 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.25514255 |
60 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.23767285 |
61 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.23445313 |
62 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.23200425 |
63 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.22861821 |
64 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.22154088 |
65 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.21710468 |
66 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.19896908 |
67 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.18983146 |
68 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.18581589 |
69 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.18529507 |
70 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.18282428 |
71 | * TP53_18474530_ChIP-ChIP_U2OS_Human | 1.14380979 |
72 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 1.14366599 |
73 | * TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.13389385 |
74 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.13240747 |
75 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.12256118 |
76 | * NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.12145616 |
77 | SA1_22415368_ChIP-Seq_MEFs_Mouse | 1.11851173 |
78 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.10888006 |
79 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.09875346 |
80 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.08715323 |
81 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.08505484 |
82 | KDM2B_26808549_Chip-Seq_K562_Human | 1.08397327 |
83 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.07923113 |
84 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.07166210 |
85 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.07141772 |
86 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.06623168 |
87 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.06189754 |
88 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.05793453 |
89 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.05793453 |
90 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.04976217 |
91 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.04784142 |
92 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.04784142 |
93 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.04635126 |
94 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.04224811 |
95 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.02854134 |
96 | AR_25329375_ChIP-Seq_VCAP_Human | 1.02456855 |
97 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.01507181 |
98 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.00701715 |
99 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.00541089 |
100 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.00364941 |
101 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.00137365 |
102 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.99668220 |
103 | * CJUN_26792858_Chip-Seq_BT549_Human | 0.98582686 |
104 | * TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.98325206 |
105 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.98196591 |
106 | * AR_19668381_ChIP-Seq_PC3_Human | 0.97765286 |
107 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.97519387 |
108 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.97307954 |
109 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.96566035 |
110 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.95875526 |
111 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.95479495 |
112 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.94920912 |
113 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.93684350 |
114 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.93338587 |
115 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.93338587 |
116 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.92431164 |
117 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.92103096 |
118 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.92017214 |
119 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.91890121 |
120 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.91723886 |
121 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.91329989 |
122 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.90459384 |
123 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.90055770 |
124 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.89443823 |
125 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.89371635 |
126 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.87991223 |
127 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 0.87607936 |
128 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.86265696 |
129 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.86127429 |
130 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.86090827 |
131 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.85880632 |
132 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.84798708 |
133 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.83868925 |
134 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.83592470 |
135 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.83425089 |
136 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.83402651 |
137 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.82932508 |
138 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.80936895 |
139 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.80386750 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002254_reproductive_system_inflammat | 4.48164951 |
2 | MP0003329_amyloid_beta_deposits | 3.37874999 |
3 | MP0003279_aneurysm | 3.22090631 |
4 | MP0003690_abnormal_glial_cell | 3.15298956 |
5 | MP0009384_cardiac_valve_regurgitation | 3.06693778 |
6 | MP0004858_abnormal_nervous_system | 2.77401422 |
7 | MP0004885_abnormal_endolymph | 2.71862514 |
8 | MP0010368_abnormal_lymphatic_system | 2.53969902 |
9 | MP0005257_abnormal_intraocular_pressure | 2.44587751 |
10 | MP0009780_abnormal_chondrocyte_physiolo | 2.42813553 |
11 | MP0004859_abnormal_synaptic_plasticity | 2.40650778 |
12 | MP0008438_abnormal_cutaneous_collagen | 2.26428458 |
13 | MP0005377_hearing/vestibular/ear_phenot | 2.13036903 |
14 | MP0003878_abnormal_ear_physiology | 2.13036903 |
15 | MP0005646_abnormal_pituitary_gland | 2.08204212 |
16 | MP0009840_abnormal_foam_cell | 2.03626440 |
17 | MP0005623_abnormal_meninges_morphology | 2.00323537 |
18 | MP0000751_myopathy | 1.99250227 |
19 | MP0002060_abnormal_skin_morphology | 1.99178027 |
20 | MP0001486_abnormal_startle_reflex | 1.97521910 |
21 | MP0005023_abnormal_wound_healing | 1.95227414 |
22 | MP0000566_synostosis | 1.93699129 |
23 | MP0001502_abnormal_circadian_rhythm | 1.91882785 |
24 | MP0001958_emphysema | 1.89578732 |
25 | MP0004215_abnormal_myocardial_fiber | 1.87341207 |
26 | MP0002896_abnormal_bone_mineralization | 1.86208749 |
27 | MP0000604_amyloidosis | 1.83677655 |
28 | MP0006054_spinal_hemorrhage | 1.78403680 |
29 | MP0000767_abnormal_smooth_muscle | 1.77588367 |
30 | MP0003075_altered_response_to | 1.68670190 |
31 | MP0003635_abnormal_synaptic_transmissio | 1.68462802 |
32 | MP0003705_abnormal_hypodermis_morpholog | 1.66756882 |
33 | MP0002909_abnormal_adrenal_gland | 1.65084355 |
34 | MP0003634_abnormal_glial_cell | 1.60182296 |
35 | MP0005058_abnormal_lysosome_morphology | 1.53690417 |
36 | MP0001440_abnormal_grooming_behavior | 1.49173738 |
37 | MP0008569_lethality_at_weaning | 1.48027377 |
38 | MP0005275_abnormal_skin_tensile | 1.47640307 |
39 | MP0003283_abnormal_digestive_organ | 1.47255205 |
40 | MP0003137_abnormal_impulse_conducting | 1.44766024 |
41 | MP0009046_muscle_twitch | 1.43564411 |
42 | MP0010030_abnormal_orbit_morphology | 1.42280217 |
43 | MP0002127_abnormal_cardiovascular_syste | 1.40451355 |
44 | MP0001849_ear_inflammation | 1.38744599 |
45 | MP0004270_analgesia | 1.36817818 |
46 | MP0001853_heart_inflammation | 1.33527797 |
47 | MP0003633_abnormal_nervous_system | 1.32475502 |
48 | MP0004272_abnormal_basement_membrane | 1.31547778 |
49 | MP0000750_abnormal_muscle_regeneration | 1.28835772 |
50 | MP0005503_abnormal_tendon_morphology | 1.28288424 |
51 | MP0002064_seizures | 1.27518228 |
52 | MP0000762_abnormal_tongue_morphology | 1.25877228 |
53 | MP0004130_abnormal_muscle_cell | 1.25106516 |
54 | MP0000920_abnormal_myelination | 1.24443220 |
55 | MP0005670_abnormal_white_adipose | 1.24278847 |
56 | MP0001299_abnormal_eye_distance/ | 1.23739524 |
57 | MP0002572_abnormal_emotion/affect_behav | 1.21322654 |
58 | MP0003941_abnormal_skin_development | 1.20180750 |
59 | MP0002063_abnormal_learning/memory/cond | 1.19614845 |
60 | MP0002998_abnormal_bone_remodeling | 1.16491244 |
61 | MP0002638_abnormal_pupillary_reflex | 1.16367361 |
62 | MP0005332_abnormal_amino_acid | 1.15440978 |
63 | MP0005167_abnormal_blood-brain_barrier | 1.15150596 |
64 | MP0002733_abnormal_thermal_nociception | 1.14586706 |
65 | MP0001879_abnormal_lymphatic_vessel | 1.14339682 |
66 | MP0002295_abnormal_pulmonary_circulatio | 1.13796485 |
67 | MP0003191_abnormal_cellular_cholesterol | 1.11678082 |
68 | MP0003631_nervous_system_phenotype | 1.10882383 |
69 | MP0009745_abnormal_behavioral_response | 1.10795756 |
70 | MP0005409_darkened_coat_color | 1.09727816 |
71 | MP0005165_increased_susceptibility_to | 1.08907286 |
72 | MP0003632_abnormal_nervous_system | 1.07990377 |
73 | MP0003646_muscle_fatigue | 1.07260477 |
74 | MP0002090_abnormal_vision | 1.06055934 |
75 | MP0002972_abnormal_cardiac_muscle | 1.05703415 |
76 | MP0003011_delayed_dark_adaptation | 1.05653994 |
77 | MP0003136_yellow_coat_color | 1.05539404 |
78 | MP0002089_abnormal_postnatal_growth/wei | 1.05270942 |
79 | MP0003566_abnormal_cell_adhesion | 1.04969118 |
80 | MP0005390_skeleton_phenotype | 1.04712765 |
81 | MP0000733_abnormal_muscle_development | 1.03550534 |
82 | MP0005595_abnormal_vascular_smooth | 1.01516797 |
83 | MP0001243_abnormal_dermal_layer | 1.01339467 |
84 | MP0000013_abnormal_adipose_tissue | 1.00161266 |
85 | MP0000003_abnormal_adipose_tissue | 0.99162768 |
86 | MP0005164_abnormal_response_to | 0.98876277 |
87 | MP0005423_abnormal_somatic_nervous | 0.98206297 |
88 | MP0005508_abnormal_skeleton_morphology | 0.97680075 |
89 | MP0001485_abnormal_pinna_reflex | 0.95866060 |
90 | MP0005388_respiratory_system_phenotype | 0.95772678 |
91 | MP0002133_abnormal_respiratory_system | 0.95772678 |
92 | MP0000759_abnormal_skeletal_muscle | 0.94818371 |
93 | MP0003091_abnormal_cell_migration | 0.94770563 |
94 | MP0000163_abnormal_cartilage_morphology | 0.93801643 |
95 | MP0001984_abnormal_olfaction | 0.93051362 |
96 | MP0004036_abnormal_muscle_relaxation | 0.92350386 |
97 | MP0000428_abnormal_craniofacial_morphol | 0.91822019 |
98 | MP0000049_abnormal_middle_ear | 0.91723135 |
99 | MP0005666_abnormal_adipose_tissue | 0.91555038 |
100 | MP0000467_abnormal_esophagus_morphology | 0.90997773 |
101 | MP0000343_altered_response_to | 0.89807876 |
102 | MP0005620_abnormal_muscle_contractility | 0.89666636 |
103 | MP0003828_pulmonary_edema | 0.89303917 |
104 | MP0001501_abnormal_sleep_pattern | 0.88615300 |
105 | MP0003300_gastrointestinal_ulcer | 0.88473967 |
106 | MP0002557_abnormal_social/conspecific_i | 0.88117243 |
107 | MP0000647_abnormal_sebaceous_gland | 0.87739131 |
108 | MP0002115_abnormal_skeleton_extremities | 0.86604049 |
109 | MP0009250_abnormal_appendicular_skeleto | 0.85456681 |
110 | MP0002108_abnormal_muscle_morphology | 0.84336906 |
111 | MP0002736_abnormal_nociception_after | 0.83834447 |
112 | MP0002734_abnormal_mechanical_nocicepti | 0.82337413 |
113 | MP0005551_abnormal_eye_electrophysiolog | 0.81635165 |
114 | MP0003448_altered_tumor_morphology | 0.80955277 |
115 | MP0002933_joint_inflammation | 0.80510349 |
116 | MP0001542_abnormal_bone_strength | 0.78734992 |
117 | MP0005375_adipose_tissue_phenotype | 0.77905546 |
118 | MP0003950_abnormal_plasma_membrane | 0.77851458 |
119 | MP0005379_endocrine/exocrine_gland_phen | 0.77141898 |
120 | MP0005171_absent_coat_pigmentation | 0.77001151 |
121 | MP0000747_muscle_weakness | 0.76945301 |
122 | MP0003453_abnormal_keratinocyte_physiol | 0.76535420 |
123 | MP0000534_abnormal_ureter_morphology | 0.76394280 |
124 | MP0000579_abnormal_nail_morphology | 0.76259197 |
125 | MP0006138_congestive_heart_failure | 0.75741968 |
126 | MP0001915_intracranial_hemorrhage | 0.73766828 |
127 | MP0000462_abnormal_digestive_system | 0.73759061 |
128 | MP0002113_abnormal_skeleton_development | 0.73408022 |
129 | MP0003385_abnormal_body_wall | 0.72536210 |
130 | MP0002249_abnormal_larynx_morphology | 0.72409963 |
131 | MP0009115_abnormal_fat_cell | 0.72383993 |
132 | MP0001533_abnormal_skeleton_physiology | 0.72147068 |
133 | MP0001970_abnormal_pain_threshold | 0.71187568 |
134 | MP0003795_abnormal_bone_structure | 0.71082380 |
135 | MP0004883_abnormal_blood_vessel | 0.70917189 |
136 | MP0005253_abnormal_eye_physiology | 0.70901174 |
137 | MP0004084_abnormal_cardiac_muscle | 0.70721097 |
138 | MP0005647_abnormal_sex_gland | 0.70504457 |
139 | MP0003045_fibrosis | 0.70171732 |
140 | MP0004233_abnormal_muscle_weight | 0.70082577 |
141 | MP0002971_abnormal_brown_adipose | 0.69708054 |
142 | MP0001177_atelectasis | 0.69539493 |
143 | MP0002067_abnormal_sensory_capabilities | 0.68999002 |
144 | MP0000749_muscle_degeneration | 0.68640979 |
145 | MP0002168_other_aberrant_phenotype | 0.68082228 |
146 | MP0009053_abnormal_anal_canal | 0.67230843 |
147 | MP0004510_myositis | 0.66664385 |
148 | MP0002128_abnormal_blood_circulation | 0.64188925 |
149 | MP0004087_abnormal_muscle_fiber | 0.63901922 |
150 | MP0001614_abnormal_blood_vessel | 0.62804594 |
151 | MP0000249_abnormal_blood_vessel | 0.59446796 |
152 | MP0002877_abnormal_melanocyte_morpholog | 0.57741710 |
153 | MP0010771_integument_phenotype | 0.56489418 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Aplasia involving bones of the extremities (HP:0009825) | 6.78328387 |
2 | Aplasia involving bones of the upper limbs (HP:0009823) | 6.78328387 |
3 | Aplasia of the phalanges of the hand (HP:0009802) | 6.78328387 |
4 | Megalencephaly (HP:0001355) | 6.31320293 |
5 | Neurofibrillary tangles (HP:0002185) | 4.80873644 |
6 | Vascular tortuosity (HP:0004948) | 4.17573634 |
7 | Hypoplastic left heart (HP:0004383) | 3.92949284 |
8 | Arterial tortuosity (HP:0005116) | 3.83997378 |
9 | Aortic aneurysm (HP:0004942) | 3.77802316 |
10 | Fragile skin (HP:0001030) | 3.76155704 |
11 | Cerebral inclusion bodies (HP:0100314) | 3.74166150 |
12 | Abnormality of the axillary hair (HP:0100134) | 3.65600423 |
13 | Abnormality of secondary sexual hair (HP:0009888) | 3.65600423 |
14 | Bladder diverticulum (HP:0000015) | 3.62638254 |
15 | Hemiparesis (HP:0001269) | 3.62139223 |
16 | Mesangial abnormality (HP:0001966) | 3.56628324 |
17 | Abnormality of binocular vision (HP:0011514) | 3.55118285 |
18 | Diplopia (HP:0000651) | 3.55118285 |
19 | Hemiplegia (HP:0002301) | 3.54571524 |
20 | Soft skin (HP:0000977) | 3.46253889 |
21 | Onycholysis (HP:0001806) | 3.45166765 |
22 | Vertebral compression fractures (HP:0002953) | 3.39932652 |
23 | Wormian bones (HP:0002645) | 3.39433117 |
24 | Short hallux (HP:0010109) | 3.26344357 |
25 | Cervical subluxation (HP:0003308) | 3.21906268 |
26 | Spinal rigidity (HP:0003306) | 3.12413274 |
27 | Neonatal short-limb short stature (HP:0008921) | 3.07078510 |
28 | Hypoplastic heart (HP:0001961) | 3.05026569 |
29 | Type 1 muscle fiber predominance (HP:0003803) | 3.01526823 |
30 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 3.00366933 |
31 | Clumsiness (HP:0002312) | 2.99990381 |
32 | Spondylolisthesis (HP:0003302) | 2.95325316 |
33 | Humeroradial synostosis (HP:0003041) | 2.91759404 |
34 | Synostosis involving the elbow (HP:0003938) | 2.91759404 |
35 | Blue sclerae (HP:0000592) | 2.91149599 |
36 | Increased variability in muscle fiber diameter (HP:0003557) | 2.88433291 |
37 | Abnormality of the middle phalanges of the toes (HP:0010183) | 2.87091271 |
38 | Genu recurvatum (HP:0002816) | 2.84703272 |
39 | Dilatation of the ascending aorta (HP:0005111) | 2.75092018 |
40 | Abnormality of proline metabolism (HP:0010907) | 2.61617788 |
41 | Hydroxyprolinuria (HP:0003080) | 2.61617788 |
42 | Tetraparesis (HP:0002273) | 2.60827039 |
43 | Premature rupture of membranes (HP:0001788) | 2.58659187 |
44 | Slender build (HP:0001533) | 2.57330504 |
45 | Abnormality of the dental pulp (HP:0006479) | 2.53287952 |
46 | Broad metatarsal (HP:0001783) | 2.52497001 |
47 | Mixed hearing impairment (HP:0000410) | 2.51740952 |
48 | Peritonitis (HP:0002586) | 2.49329961 |
49 | Fibular aplasia (HP:0002990) | 2.48127874 |
50 | Osteolytic defects of the hand bones (HP:0009699) | 2.46885603 |
51 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.46885603 |
52 | Bowel diverticulosis (HP:0005222) | 2.46844681 |
53 | Protrusio acetabuli (HP:0003179) | 2.46445684 |
54 | Mild short stature (HP:0003502) | 2.44861127 |
55 | Adactyly (HP:0009776) | 2.44262917 |
56 | Long nose (HP:0003189) | 2.43917666 |
57 | Mitral regurgitation (HP:0001653) | 2.43721247 |
58 | Narrow nasal bridge (HP:0000446) | 2.41303131 |
59 | Coronal craniosynostosis (HP:0004440) | 2.40835748 |
60 | Bronchomalacia (HP:0002780) | 2.39696181 |
61 | Hyperextensible skin (HP:0000974) | 2.39166160 |
62 | Mitral valve prolapse (HP:0001634) | 2.38250136 |
63 | Mitral stenosis (HP:0001718) | 2.34230859 |
64 | Hyperglycinuria (HP:0003108) | 2.31229297 |
65 | Absent hair (HP:0002298) | 2.30610797 |
66 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.30563523 |
67 | Shallow orbits (HP:0000586) | 2.28019388 |
68 | Joint stiffness (HP:0001387) | 2.23397656 |
69 | Abnormality of nail color (HP:0100643) | 2.23118751 |
70 | Supranuclear gaze palsy (HP:0000605) | 2.22591164 |
71 | Atrophic scars (HP:0001075) | 2.21017552 |
72 | Wrist flexion contracture (HP:0001239) | 2.20402678 |
73 | Hypoalphalipoproteinemia (HP:0003233) | 2.19735471 |
74 | Joint laxity (HP:0001388) | 2.18617880 |
75 | Aplasia/Hypoplasia of the middle phalanx of the 5th finger (HP:0009161) | 2.18158604 |
76 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.17226412 |
77 | Abnormality of molar morphology (HP:0011070) | 2.16672836 |
78 | Abnormality of molar (HP:0011077) | 2.16672836 |
79 | Short middle phalanx of the 5th finger (HP:0004220) | 2.15102497 |
80 | Coxa vara (HP:0002812) | 2.12304502 |
81 | Aortic regurgitation (HP:0001659) | 2.11749866 |
82 | Absent frontal sinuses (HP:0002688) | 2.09426922 |
83 | Split foot (HP:0001839) | 2.09040612 |
84 | Abnormality of permanent molar morphology (HP:0011071) | 2.08132030 |
85 | Abnormality of the dental root (HP:0006486) | 2.08132030 |
86 | Taurodontia (HP:0000679) | 2.08132030 |
87 | Turricephaly (HP:0000262) | 2.06999574 |
88 | Ulnar bowing (HP:0003031) | 2.05936392 |
89 | Atrioventricular block (HP:0001678) | 2.05084028 |
90 | Overgrowth (HP:0001548) | 2.04832449 |
91 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.04648707 |
92 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.04648707 |
93 | Abnormality of glycolipid metabolism (HP:0010969) | 2.04648707 |
94 | Aneurysm (HP:0002617) | 2.04273690 |
95 | Increased connective tissue (HP:0009025) | 2.03015752 |
96 | Hypoplasia of the iris (HP:0007676) | 2.01791722 |
97 | Ectopia lentis (HP:0001083) | 2.01650076 |
98 | Exercise-induced myalgia (HP:0003738) | 2.00052730 |
99 | Absent toe (HP:0010760) | 1.99917152 |
100 | Natal tooth (HP:0000695) | 1.99366280 |
101 | Ovoid vertebral bodies (HP:0003300) | 1.98978216 |
102 | Abnormal delivery (HP:0001787) | 1.97090537 |
103 | Generalized amyotrophy (HP:0003700) | 1.96397900 |
104 | Aplasia/Hypoplasia of the phalanges of the 5th finger (HP:0009376) | 1.96340237 |
105 | Milia (HP:0001056) | 1.96189862 |
106 | Selective tooth agenesis (HP:0001592) | 1.96096862 |
107 | Status epilepticus (HP:0002133) | 1.96078182 |
108 | Aortic valve stenosis (HP:0001650) | 1.95809123 |
109 | Facial shape deformation (HP:0011334) | 1.94536512 |
110 | Potter facies (HP:0002009) | 1.94536512 |
111 | Follicular hyperkeratosis (HP:0007502) | 1.94398335 |
112 | Abnormality of the acetabulum (HP:0003170) | 1.94079009 |
113 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 1.92284068 |
114 | Elbow flexion contracture (HP:0002987) | 1.92039448 |
115 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.90308290 |
116 | Abnormality of glycine metabolism (HP:0010895) | 1.90308290 |
117 | Wide anterior fontanel (HP:0000260) | 1.89536738 |
118 | Abnormality of the middle phalanx of the 5th finger (HP:0004219) | 1.89457196 |
119 | Abnormality of dentin (HP:0010299) | 1.89071119 |
120 | Systemic lupus erythematosus (HP:0002725) | 1.88882911 |
121 | Craniofacial hyperostosis (HP:0004493) | 1.88339302 |
122 | Complement deficiency (HP:0004431) | 1.87507432 |
123 | Dysostosis multiplex (HP:0000943) | 1.86717644 |
124 | Cupped ribs (HP:0000887) | 1.86515060 |
125 | Spinal cord compression (HP:0002176) | 1.85602350 |
126 | Round ear (HP:0100830) | 1.85581809 |
127 | Osteoarthritis (HP:0002758) | 1.84876162 |
128 | Limited hip movement (HP:0008800) | 1.84487773 |
129 | Biconcave vertebral bodies (HP:0004586) | 1.83860830 |
130 | Abnormality of complement system (HP:0005339) | 1.81253695 |
131 | Obstructive sleep apnea (HP:0002870) | 1.80064422 |
132 | Nuclear cataract (HP:0100018) | 1.79893754 |
133 | Heart block (HP:0012722) | 1.79862061 |
134 | Myokymia (HP:0002411) | 1.79641430 |
135 | Hypoventilation (HP:0002791) | 1.78652754 |
136 | Distal upper limb amyotrophy (HP:0007149) | 1.78417489 |
137 | Upper limb amyotrophy (HP:0009129) | 1.78417489 |
138 | Abnormal atrioventricular conduction (HP:0005150) | 1.76562187 |
139 | Venous abnormality (HP:0002624) | 1.76229085 |
140 | Short nail (HP:0001799) | 1.76160060 |
141 | Tibial bowing (HP:0002982) | 1.76025564 |
142 | Action tremor (HP:0002345) | 1.75569594 |
143 | Broad hallux (HP:0010055) | 1.75513178 |
144 | Ankle contracture (HP:0006466) | 1.75352830 |
145 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 1.75244338 |
146 | Flared iliac wings (HP:0002869) | 1.74866115 |
147 | Epileptic encephalopathy (HP:0200134) | 1.74736802 |
148 | Tarsal synostosis (HP:0008368) | 1.74611702 |
149 | Aortic dissection (HP:0002647) | 1.73309143 |
150 | Mucopolysacchariduria (HP:0008155) | 1.73214684 |
151 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.73214684 |
152 | Abnormality of the phalanges of the 5th finger (HP:0004213) | 1.72805839 |
153 | Focal motor seizures (HP:0011153) | 1.71611520 |
154 | Pterygium (HP:0001059) | 1.70642480 |
155 | Popliteal pterygium (HP:0009756) | 1.70590008 |
156 | Cerebral aneurysm (HP:0004944) | 1.70521613 |
157 | Venous insufficiency (HP:0005293) | 1.69700679 |
158 | Abnormal urine output (HP:0012590) | 1.69424454 |
159 | Cardiovascular calcification (HP:0011915) | 1.68972211 |
160 | Axonal loss (HP:0003447) | 1.68793109 |
161 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.68766110 |
162 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.68766110 |
163 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.68766110 |
164 | Fragile nails (HP:0001808) | 1.68492915 |
165 | Maternal diabetes (HP:0009800) | 1.67703126 |
166 | Broad ribs (HP:0000885) | 1.67021185 |
167 | Confusion (HP:0001289) | 1.65720715 |
168 | Multifactorial inheritance (HP:0001426) | 1.64727971 |
169 | Athetosis (HP:0002305) | 1.64244833 |
170 | Cranial hyperostosis (HP:0004437) | 1.61868281 |
171 | Synostosis involving bones of the lower limbs (HP:0009138) | 1.61279402 |
172 | Synostosis involving bones of the feet (HP:0009140) | 1.61279402 |
173 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 1.61179598 |
174 | Asymmetric septal hypertrophy (HP:0001670) | 1.61152625 |
175 | Infantile muscular hypotonia (HP:0008947) | 1.58318085 |
176 | Blepharitis (HP:0000498) | 1.58046563 |
177 | Xanthomatosis (HP:0000991) | 1.56481828 |
178 | Aplasia/Hypoplasia of the fibula (HP:0006492) | 1.55874611 |
179 | Polygenic inheritance (HP:0010982) | 1.55559332 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EPHA4 | 5.52406001 |
2 | LMTK2 | 5.42128514 |
3 | PHKG2 | 4.00874196 |
4 | PHKG1 | 4.00874196 |
5 | TRIB3 | 3.57932872 |
6 | MUSK | 3.09054546 |
7 | TGFBR2 | 2.73755911 |
8 | TNIK | 2.52149612 |
9 | PRKD3 | 2.51168481 |
10 | MOS | 2.33886412 |
11 | SIK1 | 2.28420813 |
12 | NTRK2 | 2.20604327 |
13 | ARAF | 2.16980392 |
14 | DDR2 | 2.06072759 |
15 | TESK1 | 1.98329535 |
16 | LIMK1 | 1.72750909 |
17 | MAPK12 | 1.66658908 |
18 | NTRK3 | 1.59189222 |
19 | PAK2 | 1.54997322 |
20 | TIE1 | 1.54143070 |
21 | MARK1 | 1.50920918 |
22 | NEK9 | 1.49059309 |
23 | PDGFRA | 1.49038469 |
24 | PAK4 | 1.47834555 |
25 | RIPK1 | 1.43909750 |
26 | BMX | 1.29465419 |
27 | PIM2 | 1.28170877 |
28 | TTN | 1.27869522 |
29 | NTRK1 | 1.21241346 |
30 | ABL2 | 1.20599668 |
31 | MINK1 | 1.18068395 |
32 | ADRBK1 | 1.17525669 |
33 | DMPK | 1.16458525 |
34 | SGK223 | 1.10978835 |
35 | SGK494 | 1.10978835 |
36 | STK38 | 1.09969817 |
37 | LATS2 | 1.04697709 |
38 | SGK2 | 1.03712836 |
39 | PAK6 | 1.02311183 |
40 | SGK3 | 1.02168886 |
41 | PDK3 | 1.01995366 |
42 | PDK4 | 1.01995366 |
43 | PAK3 | 1.00400846 |
44 | MAP3K9 | 0.96715671 |
45 | ROCK1 | 0.95063222 |
46 | TYRO3 | 0.91557995 |
47 | CAMK1D | 0.91141953 |
48 | FGR | 0.87700985 |
49 | KSR2 | 0.86764344 |
50 | FGFR1 | 0.85722165 |
51 | FGFR2 | 0.84812006 |
52 | PINK1 | 0.84197569 |
53 | DAPK3 | 0.83665210 |
54 | RPS6KA2 | 0.81781315 |
55 | PRKCG | 0.81752298 |
56 | ERN1 | 0.80022032 |
57 | MAP3K6 | 0.79864046 |
58 | CAMK1G | 0.78414876 |
59 | CAMKK1 | 0.77340575 |
60 | MARK2 | 0.76873407 |
61 | CDK5 | 0.76404610 |
62 | MAP3K13 | 0.75829928 |
63 | EPHB2 | 0.74722565 |
64 | PRKCH | 0.73153327 |
65 | ICK | 0.73009920 |
66 | PRPF4B | 0.72861802 |
67 | MAPK7 | 0.72188606 |
68 | CAMK2B | 0.72073506 |
69 | ROCK2 | 0.71871788 |
70 | FER | 0.71682811 |
71 | PRKG2 | 0.71256568 |
72 | TNK2 | 0.70471259 |
73 | PRKCE | 0.69781416 |
74 | ERBB4 | 0.68731538 |
75 | JAK1 | 0.68483021 |
76 | MET | 0.68423052 |
77 | PTK2B | 0.67872959 |
78 | MAPK13 | 0.66698350 |
79 | CAMK2A | 0.65813583 |
80 | CDC42BPA | 0.65754703 |
81 | BCKDK | 0.65543154 |
82 | MAP3K4 | 0.65120759 |
83 | UHMK1 | 0.62716510 |
84 | MAP3K7 | 0.61033263 |
85 | LRRK2 | 0.61019998 |
86 | PDK2 | 0.60506117 |
87 | PRKD2 | 0.60395109 |
88 | TRPM7 | 0.59549094 |
89 | DAPK2 | 0.59513906 |
90 | GRK5 | 0.59425364 |
91 | PKN1 | 0.58262278 |
92 | MAP3K3 | 0.58078758 |
93 | CAMK2D | 0.57566854 |
94 | WNK4 | 0.56552121 |
95 | MTOR | 0.55665400 |
96 | PTK2 | 0.53794254 |
97 | MAPK4 | 0.53016356 |
98 | PTK6 | 0.52396312 |
99 | FGFR3 | 0.52394786 |
100 | MAP2K1 | 0.52273986 |
101 | PIK3CG | 0.51693592 |
102 | GSK3A | 0.51607689 |
103 | CASK | 0.51352082 |
104 | MYLK | 0.50874709 |
105 | EPHB1 | 0.49957378 |
106 | PKN2 | 0.49840177 |
107 | PRKD1 | 0.49671061 |
108 | CAMK1 | 0.49437499 |
109 | FGFR4 | 0.48340294 |
110 | IGF1R | 0.47393568 |
111 | PDPK1 | 0.47337171 |
112 | OXSR1 | 0.46776409 |
113 | SGK1 | 0.46593467 |
114 | SRC | 0.45726440 |
115 | CDK11A | 0.45264540 |
116 | MAPKAPK5 | 0.44731410 |
117 | TGFBR1 | 0.44640252 |
118 | PLK2 | 0.44249569 |
119 | TAOK2 | 0.44187156 |
120 | LATS1 | 0.44119890 |
121 | PRKAA2 | 0.44027702 |
122 | RET | 0.43506052 |
123 | WNK1 | 0.42933071 |
124 | DYRK1A | 0.41840949 |
125 | KIT | 0.41815645 |
126 | CDK15 | 0.41775578 |
127 | MAPKAPK3 | 0.41565822 |
128 | PRKACG | 0.41444118 |
129 | CDK14 | 0.41209340 |
130 | GRK6 | 0.40915496 |
131 | ILK | 0.40771963 |
132 | MST1R | 0.40266511 |
133 | CAMK2G | 0.40221234 |
134 | BRAF | 0.39628892 |
135 | PRKCA | 0.38718879 |
136 | MAP3K2 | 0.38493118 |
137 | IRAK3 | 0.37305303 |
138 | CDK18 | 0.37227290 |
139 | PRKACA | 0.37160804 |
140 | AKT2 | 0.35931989 |
141 | RPS6KA3 | 0.35572581 |
142 | PRKAA1 | 0.35053296 |
143 | PDGFRB | 0.33256613 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 4.95598530 |
2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 4.71439687 |
3 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 3.24505319 |
4 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.66194460 |
5 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.34215934 |
6 | Prion diseases_Homo sapiens_hsa05020 | 1.94313232 |
7 | Amoebiasis_Homo sapiens_hsa05146 | 1.84436129 |
8 | Other glycan degradation_Homo sapiens_hsa00511 | 1.70596122 |
9 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.70500784 |
10 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.62029481 |
11 | Nicotine addiction_Homo sapiens_hsa05033 | 1.55063927 |
12 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.51714922 |
13 | Salivary secretion_Homo sapiens_hsa04970 | 1.47507724 |
14 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.41237315 |
15 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.39436691 |
16 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.37988216 |
17 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.36287704 |
18 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.34711548 |
19 | GABAergic synapse_Homo sapiens_hsa04727 | 1.30910119 |
20 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.23456488 |
21 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.22642645 |
22 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.21678990 |
23 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.18037303 |
24 | Circadian rhythm_Homo sapiens_hsa04710 | 1.16003918 |
25 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 1.15254540 |
26 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.14556026 |
27 | Insulin secretion_Homo sapiens_hsa04911 | 1.13626999 |
28 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.13226871 |
29 | Bile secretion_Homo sapiens_hsa04976 | 1.12841449 |
30 | Glioma_Homo sapiens_hsa05214 | 1.06737141 |
31 | Cocaine addiction_Homo sapiens_hsa05030 | 1.06634244 |
32 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.06581774 |
33 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.06249560 |
34 | Circadian entrainment_Homo sapiens_hsa04713 | 1.05232903 |
35 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.02767462 |
36 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.00333625 |
37 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.99543454 |
38 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.97446285 |
39 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.96589533 |
40 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.96563221 |
41 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.95043186 |
42 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.94396333 |
43 | Mineral absorption_Homo sapiens_hsa04978 | 0.92870788 |
44 | Adherens junction_Homo sapiens_hsa04520 | 0.90917593 |
45 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.89846787 |
46 | Long-term potentiation_Homo sapiens_hsa04720 | 0.88361868 |
47 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.87753059 |
48 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.87678838 |
49 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.87491604 |
50 | Bladder cancer_Homo sapiens_hsa05219 | 0.87284682 |
51 | Olfactory transduction_Homo sapiens_hsa04740 | 0.85967543 |
52 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.85637631 |
53 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.85230959 |
54 | Morphine addiction_Homo sapiens_hsa05032 | 0.83768342 |
55 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.83387654 |
56 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.83148047 |
57 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.83010632 |
58 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.82897187 |
59 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.82502853 |
60 | Melanoma_Homo sapiens_hsa05218 | 0.82336874 |
61 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.79074810 |
62 | Pertussis_Homo sapiens_hsa05133 | 0.78917291 |
63 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.78364857 |
64 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.78328541 |
65 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.77667973 |
66 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.75629386 |
67 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.75484935 |
68 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.74047486 |
69 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.73333445 |
70 | Melanogenesis_Homo sapiens_hsa04916 | 0.72967955 |
71 | Carbon metabolism_Homo sapiens_hsa01200 | 0.72963039 |
72 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.72955781 |
73 | Focal adhesion_Homo sapiens_hsa04510 | 0.72114893 |
74 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.71749830 |
75 | Endocytosis_Homo sapiens_hsa04144 | 0.71595736 |
76 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.71504611 |
77 | Renin secretion_Homo sapiens_hsa04924 | 0.71268948 |
78 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.71167098 |
79 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.70628590 |
80 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.70046562 |
81 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.69254101 |
82 | Gap junction_Homo sapiens_hsa04540 | 0.68998743 |
83 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.68789754 |
84 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.68426729 |
85 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.68098968 |
86 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.66423740 |
87 | Lysosome_Homo sapiens_hsa04142 | 0.66411196 |
88 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.65985630 |
89 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.65949403 |
90 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.65739095 |
91 | Pathways in cancer_Homo sapiens_hsa05200 | 0.65559092 |
92 | Peroxisome_Homo sapiens_hsa04146 | 0.65421066 |
93 | Phagosome_Homo sapiens_hsa04145 | 0.65278167 |
94 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.64929390 |
95 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.64759738 |
96 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.64595608 |
97 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.64427823 |
98 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.62477038 |
99 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.61470957 |
100 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.61003041 |
101 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.60161022 |
102 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.60151567 |
103 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.60141382 |
104 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.59752059 |
105 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.59588479 |
106 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.59436824 |
107 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.59046508 |
108 | Histidine metabolism_Homo sapiens_hsa00340 | 0.58227223 |
109 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.58030054 |
110 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.57651058 |
111 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.57246588 |
112 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.56909225 |
113 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.56055272 |
114 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.55982452 |
115 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.55293200 |
116 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.55276752 |
117 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.54020775 |
118 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.53647752 |
119 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.53382949 |
120 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.53342964 |
121 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.52627655 |
122 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.52537276 |
123 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.52507293 |
124 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.51837571 |
125 | Sulfur relay system_Homo sapiens_hsa04122 | 0.50820972 |
126 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.49888929 |
127 | Axon guidance_Homo sapiens_hsa04360 | 0.49496378 |
128 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.49021623 |
129 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.49016343 |
130 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.48405919 |
131 | Taste transduction_Homo sapiens_hsa04742 | 0.48034504 |
132 | Malaria_Homo sapiens_hsa05144 | 0.47941343 |
133 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.47898932 |
134 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.46973656 |
135 | Endometrial cancer_Homo sapiens_hsa05213 | 0.45963198 |
136 | Long-term depression_Homo sapiens_hsa04730 | 0.45905155 |
137 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.45419518 |
138 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.44284993 |
139 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.44231731 |
140 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.43565274 |